Autori: Obrenovic Svetlana
| Naslov | Cost-utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle-income economy setting (Article; Early Access) |
| Autori | Obrenovic Svetlana Folic Marko M Folic Nevena D Jankovic Slobodan M |
| Info | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (2025), vol. br. , str. - |
| Projekat | Serbian Ministry of Science, Technological Development and Innovations [175007, 451-03-137/2025-03/200111] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
